VTN and dementia: Compared with healthy controls, patients with AD have higher levels of complement proteins in astrocyte-derived exosomes (ADEs), such as C1q, C46, and factor B. The mean levels of complement proteins in ADEs are significantly higher in the moderate dementia stage than in the preclinical stage.